↓ Skip to main content

Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country

Overview of attention for article published in Frontiers in oncology, July 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country
Published in
Frontiers in oncology, July 2022
DOI 10.3389/fonc.2022.951310
Pubmed ID
Authors

Marina Lourenção, Julia Simões Correa Galendi, Henrique de Campos Reis Galvão, Augusto Perazzolo Antoniazzi, Rebeca Silveira Grasel, André Lopes Carvalho, Edmundo Carvalho Mauad, Jorge Henrique Caldeira de Oliveira, Rui Manuel Reis, Olena Mandrik, Edenir Inêz Palmero

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 8%
Student > Doctoral Student 2 8%
Student > Master 2 8%
Researcher 2 8%
Student > Postgraduate 2 8%
Other 0 0%
Unknown 15 60%
Readers by discipline Count As %
Medicine and Dentistry 6 24%
Biochemistry, Genetics and Molecular Biology 2 8%
Agricultural and Biological Sciences 1 4%
Psychology 1 4%
Economics, Econometrics and Finance 1 4%
Other 0 0%
Unknown 14 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 July 2022.
All research outputs
#23,491,956
of 26,169,168 outputs
Outputs from Frontiers in oncology
#16,369
of 22,913 outputs
Outputs of similar age
#375,884
of 441,003 outputs
Outputs of similar age from Frontiers in oncology
#1,239
of 1,773 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,003 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,773 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.